Delta-8 research goes back a long way, but it’s only recently that the cannabinoid has surfaced in legal market trends. What’s a licensed operator to make of it?
In this July 27 webinar, hear from Greg Gerdeman, president and CSO of NASHCX, and Justin Walsh, partner at Gleam Law, who will walk you through the scientific and legal ramifications of delta-8. You will learn the context behind this cannabinoid and the opportunities that accompany emerging consumer trends like this one. |
